Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
The Journal of Allergy and Clinical Immunology. in Practice|February 5, 2016
Enterovirus 68 Infection--Association with AsthmaRonald B MossJournal of Immune Based Therapies and Vaccines|September 9, 2009
Prospects for control of emerging infectious diseases with plasmid DNA vaccinesRonald B MossSubstance Abuse Treatment, Prevention, and Policy|February 20, 2019
Higher doses of naloxone are needed in the synthetic opiod eraRonald B Moss, Dennis J CarloAntiviral Research|April 23, 2013
The use of sialidase therapy for respiratory viral infectionsJohn M Nicholls, Ronald B Moss, Stuart M HaslamAllergy and Asthma Proceedings|August 30, 2018
Human factors study of a newly approved prefilled syringe of epinephrine for the treatment of anaphylaxisRonald B Moss, Thomas Moll, Karen Daniels, et al.Journal of Opioid Management|May 19, 2020
An open-label, randomized, single-dose, two-period, two-treatment crossover bioavailability study comparing 5 mg/0.5 mL of intramuscular naloxone hydrochloride to 2 mg/0.4 mL intramuscular naloxone hydrochloride autoinjector in healthy subjectsRonald B Moss, Fiona Carleton, Charles P Lollo, et al.Journal of Virology|December 15, 2004
CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotidesJanina Q Jiang, Amy Patrick, Ronald B Moss, et al.Advances in Virology|February 8, 2012
Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patientsRonald B Moss, Roy T Steigbigel, Rebecca L Sanders, et al.The Journal of Antimicrobial Chemotherapy|April 9, 2010
Targeting pandemic influenza: a primer on influenza antivirals and drug resistanceRonald B Moss, Richard T Davey, Roy T Steigbigel, et al.Clinical Immunology (Orlando, Fla.)|August 23, 2021
Brief report: Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patientsKavita Mathi, Yael Rosenberg-Hasson, Holden Maecker, et al.Pageof 3